US 6,342,496 B1 · Bupropion metabolites and methods of use

Abstract

Methods are disclosed which utilize metabolites of bupropion for treating disorders ameliorated by inhibition of neuronal monoamine reuptake. Such disorders include, cerebral function disorders, cigarette smoking, and incontinence.

Claims0

Dependent claims

Claims aren’t available for this document.

Facts

Application

09/510,241Filed 22 Feb 2000

Granted

29 Jan 2002

Term ends

Not estimatedThe source records don’t support an estimate.

Classification33 codes

A61K 31/5375
Having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines: 1,4-Oxazines, e.g. morpholine
A61K 31/00
Medicinal preparations containing organic active ingredients
A61K 31/135
Amines: having aromatic rings , e.g. ketamine, nortriptyline
A61K 31/137
Having aromatic rings , e.g. ketamine, nortriptyline: arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone

Bupropion metabolites and methods of use

Life of this patent

Abstract

Claims0

Bupropion metabolites and methods of use

Life of this patent

Abstract

Claims0